Incidental Mutation 'R2352:Slc22a18'
ID 246201
Institutional Source Beutler Lab
Gene Symbol Slc22a18
Ensembl Gene ENSMUSG00000000154
Gene Name solute carrier family 22 (organic cation transporter), member 18
Synonyms Orctl2, TSSC5, IMPT1, BWSCR1A, Impt1, Slc22a1l, BWR1A, p45-BWR1A
MMRRC Submission 040334-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.063) question?
Stock # R2352 (G1)
Quality Score 217
Status Not validated
Chromosome 7
Chromosomal Location 143027502-143053071 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 143051152 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Serine to Proline at position 344 (S344P)
Ref Sequence ENSEMBL: ENSMUSP00000101537 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000010904] [ENSMUST00000052348] [ENSMUST00000105917] [ENSMUST00000141988] [ENSMUST00000145943] [ENSMUST00000150791] [ENSMUST00000207425]
AlphaFold no structure available at present
Predicted Effect probably benign
Transcript: ENSMUST00000010904
SMART Domains Protein: ENSMUSP00000010904
Gene: ENSMUSG00000010760

DomainStartEndE-ValueType
PH 18 111 1.54e-5 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000052348
AA Change: S344P

PolyPhen 2 Score 0.019 (Sensitivity: 0.95; Specificity: 0.80)
SMART Domains Protein: ENSMUSP00000056082
Gene: ENSMUSG00000000154
AA Change: S344P

DomainStartEndE-ValueType
Pfam:MFS_1 14 339 1.1e-31 PFAM
Pfam:MFS_1 229 410 5.2e-11 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000105917
AA Change: S344P

PolyPhen 2 Score 0.019 (Sensitivity: 0.95; Specificity: 0.80)
SMART Domains Protein: ENSMUSP00000101537
Gene: ENSMUSG00000000154
AA Change: S344P

DomainStartEndE-ValueType
Pfam:MFS_1 14 337 7.8e-32 PFAM
Pfam:MFS_3 66 346 6.5e-9 PFAM
Pfam:MFS_1 229 410 3.2e-11 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000141988
Predicted Effect probably benign
Transcript: ENSMUST00000145943
SMART Domains Protein: ENSMUSP00000115345
Gene: ENSMUSG00000000154

DomainStartEndE-ValueType
transmembrane domain 13 35 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000150791
Predicted Effect probably benign
Transcript: ENSMUST00000207425
Coding Region Coverage
  • 1x: 99.3%
  • 3x: 98.7%
  • 10x: 97.3%
  • 20x: 95.0%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene is imprinted, with preferential expression from the maternal allele. Mutations in this gene have been found in Wilms' tumor and lung cancer. This protein may act as a transporter of organic cations, and have a role in the transport of chloroquine and quinidine-related compounds in kidney. Several alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Oct 2015]
Allele List at MGI
Other mutations in this stock
Total: 51 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Ankrd28 C T 14: 31,432,904 (GRCm39) V548I probably benign Het
Aspm T C 1: 139,385,300 (GRCm39) S315P probably benign Het
Caln1 G T 5: 130,534,993 (GRCm39) E70* probably null Het
Cd69 A T 6: 129,246,567 (GRCm39) W114R probably damaging Het
Cnbd2 T C 2: 156,177,275 (GRCm39) Y90H probably damaging Het
Crebrf C T 17: 26,961,320 (GRCm39) S147F probably damaging Het
Cts7 A T 13: 61,500,586 (GRCm39) C320* probably null Het
Dgat1 T C 15: 76,386,513 (GRCm39) I474V possibly damaging Het
Dmxl2 T A 9: 54,301,146 (GRCm39) I2322F probably damaging Het
Dnah11 A T 12: 117,892,065 (GRCm39) F3703I probably damaging Het
Foxb2 A G 19: 16,850,433 (GRCm39) L191P unknown Het
Gli3 A T 13: 15,836,977 (GRCm39) E453D probably benign Het
Gnl3 C T 14: 30,738,783 (GRCm39) probably null Het
Golgb1 A T 16: 36,718,921 (GRCm39) T276S probably damaging Het
Grk4 T C 5: 34,826,520 (GRCm39) M40T probably benign Het
Hoxb1 A G 11: 96,257,203 (GRCm39) N184S possibly damaging Het
Insr G T 8: 3,242,593 (GRCm39) T42N probably damaging Het
Iqgap3 A G 3: 88,011,815 (GRCm39) K836E possibly damaging Het
Kremen1 CGGG CGGGGGG 11: 5,151,791 (GRCm39) probably benign Het
Leng9 T A 7: 4,152,409 (GRCm39) E89V probably damaging Het
Lhcgr C T 17: 89,049,727 (GRCm39) V600I possibly damaging Het
Lima1 T C 15: 99,692,396 (GRCm39) N183S probably benign Het
Lmtk2 A G 5: 144,110,729 (GRCm39) D483G probably benign Het
Lpcat2b T G 5: 107,581,307 (GRCm39) L212R probably damaging Het
Lrrc61 A T 6: 48,545,806 (GRCm39) I210F probably benign Het
Lypd8l G A 11: 58,502,934 (GRCm39) Q72* probably null Het
Lypd8l A T 11: 58,503,676 (GRCm39) L10H probably damaging Het
Med12l C T 3: 59,148,113 (GRCm39) L977F probably damaging Het
Mical1 A T 10: 41,358,229 (GRCm39) D414V probably benign Het
Mmp14 C T 14: 54,678,002 (GRCm39) A541V probably benign Het
Mtmr10 A G 7: 63,947,328 (GRCm39) D81G possibly damaging Het
Myh1 G A 11: 67,111,363 (GRCm39) V1601M probably benign Het
Myo16 G A 8: 10,644,905 (GRCm39) D1746N possibly damaging Het
Neb T C 2: 52,177,348 (GRCm39) Y1331C probably damaging Het
Otop2 T C 11: 115,219,927 (GRCm39) S256P probably damaging Het
Prl8a1 A G 13: 27,759,572 (GRCm39) L155P probably damaging Het
Rrp1b A T 17: 32,278,302 (GRCm39) M658L possibly damaging Het
Sema4b C A 7: 79,870,627 (GRCm39) A525D probably damaging Het
Slc13a5 T A 11: 72,143,147 (GRCm39) I369F probably benign Het
Slc25a4 A C 8: 46,662,212 (GRCm39) S149A probably benign Het
Smc2 A T 4: 52,460,266 (GRCm39) E547D probably benign Het
Stx8 A G 11: 67,864,077 (GRCm39) T46A probably benign Het
Tacr3 T C 3: 134,560,631 (GRCm39) V190A probably benign Het
Tdrkh A T 3: 94,336,467 (GRCm39) K468M possibly damaging Het
Tmem145 T C 7: 25,005,598 (GRCm39) S4P probably benign Het
Tmem74 A G 15: 43,730,506 (GRCm39) I179T probably damaging Het
Vmn1r222 A C 13: 23,416,683 (GRCm39) W177G probably benign Het
Zfp426 T C 9: 20,381,401 (GRCm39) I529V probably benign Het
Zfp462 A G 4: 55,008,313 (GRCm39) Y93C probably null Het
Zfyve26 G A 12: 79,330,890 (GRCm39) T443I probably damaging Het
Zkscan16 A C 4: 58,951,869 (GRCm39) R181S possibly damaging Het
Other mutations in Slc22a18
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01657:Slc22a18 APN 7 143,052,837 (GRCm39) missense probably damaging 1.00
IGL01888:Slc22a18 APN 7 143,033,053 (GRCm39) missense probably damaging 1.00
IGL02458:Slc22a18 APN 7 143,046,574 (GRCm39) splice site probably benign
IGL02626:Slc22a18 APN 7 143,052,837 (GRCm39) missense probably damaging 1.00
PIT4810001:Slc22a18 UTSW 7 143,046,668 (GRCm39) missense probably benign 0.00
R0294:Slc22a18 UTSW 7 143,046,578 (GRCm39) critical splice acceptor site probably null
R0571:Slc22a18 UTSW 7 143,045,598 (GRCm39) splice site probably benign
R1951:Slc22a18 UTSW 7 143,029,984 (GRCm39) missense probably damaging 1.00
R1953:Slc22a18 UTSW 7 143,029,984 (GRCm39) missense probably damaging 1.00
R3900:Slc22a18 UTSW 7 143,033,507 (GRCm39) missense probably damaging 1.00
R5317:Slc22a18 UTSW 7 143,052,896 (GRCm39) missense probably damaging 1.00
R5428:Slc22a18 UTSW 7 143,033,082 (GRCm39) missense probably damaging 1.00
R7672:Slc22a18 UTSW 7 143,044,557 (GRCm39) missense probably damaging 1.00
R7684:Slc22a18 UTSW 7 143,044,577 (GRCm39) missense probably benign 0.00
R7688:Slc22a18 UTSW 7 143,033,560 (GRCm39) missense probably damaging 1.00
R8130:Slc22a18 UTSW 7 143,052,911 (GRCm39) missense probably damaging 1.00
R8443:Slc22a18 UTSW 7 143,051,123 (GRCm39) missense probably damaging 0.96
R9308:Slc22a18 UTSW 7 143,044,617 (GRCm39) missense probably benign 0.13
R9784:Slc22a18 UTSW 7 143,046,678 (GRCm39) missense probably benign 0.02
Z1177:Slc22a18 UTSW 7 143,050,779 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- CCAGACATCTTCCATGGTGG -3'
(R):5'- AATGGATTAGAGCCAAGTCAAATGC -3'

Sequencing Primer
(F):5'- CCATGGTGGAGCACTGTG -3'
(R):5'- GTCAAATGCCTCCTCCAGG -3'
Posted On 2014-10-30